# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Stephens covers INOVIO Pharmaceuticals highlighting its diverse clinical pipeline and FDA's consideration of INO-3107 Phase...
Stephens & Co. analyst Sudan Loganathan initiates coverage on Inovio Pharmaceuticals (NASDAQ:INO) with a Overweight rati...
Inovio Pharmaceuticals (NASDAQ:INO) reported quarterly losses of $(1.31) per share which missed the analyst consensus estimate ...
- SEC Filing
Shares of Skillsoft Corp. (NASDAQ: SKIL) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter...
Inovio announced the pricing of an underwritten offering of 2,536,258 shares of its common stock at an offering price of $7.693...
Shares of Macatawa Bank Corporation (NASDAQ: MCBC) rose sharply in today’s pre-market trading after Wintrust Financial Corpora...
U.S. stock futures were mixed this morning, with the Dow futures gaining around 100 points on Tuesday.